All terms in MESH
| Label | Id | Description |
|---|---|---|
| cholesta-5,7,9-trien-3 beta-ol | C025498 | |
| 1-stearoyl-glycerophosphate | C025499 | |
| nantradol | C025490 | |
| leukotriene C-2 | C025492 | |
| trichloromethyl-phenyl-t-butyl nitrone | C025493 | |
| L 653150 | C050450 | |
| N-(alpha-methylbenzyl)azelaamic acid | C050451 | |
| Formularies, Dental | D000078984 | [Works on or about reference lists of descriptions and uses of drugs related to oral medicine and dentistry.] |
| beta-cyclodextrin-benzaldehyde | C050452 | |
| Clinical Trial Protocols as Topic | D000078985 | [Works about the written descriptions of a clinical study. It contains the study's objectives, design, and methods including subject target and/or enrollment criteria. It may also present relevant scientific background and statistical information.] |
| Clinical Protocols | D002985 | [Precise and detailed plans for the study of a medical or biomedical problem and/or plans for a regimen of therapy.] |
| histocompatibility antigen H-8 | C050453 | |
| beta-alanyl-arginine hydrolase | C050454 | |
| fluosol | C050455 | |
| nickel-palladium alloy | C050456 | |
| 3,6-dioxa-1,8-octanedithiol | C471080 | |
| 3-((2-phenylethyl)amino)alanine | C050457 | |
| BmK Ita1 toxin, Buthus martensii | C471081 | |
| dihydrolysergic acid amide | C050458 | |
| perfluorohexanesulfonic acid | C471071 |